A. Shrestha

发表

Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Jyoti Joshi, S. Kochhar, H. Dolk, 2016, Vaccine.

Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: rationale and design of a real-world pragmatic randomized clinical trial.

A. Shrestha, M. Dupuy, I. D. de Bruijn, 2021, American heart journal.

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults >= 65 years of age: a Phase II, open-label study

A. Shrestha, S. Samson, Julie Bolduc, 2021, medRxiv.

Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial

M. Bonten, G. Icardi, A. Shrestha, 2021, Human vaccines & immunotherapeutics.

Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial.

E. Anderson, Lee-Jah Chang, Aseem Pandey, 2021, Vaccine.

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study

M. Fournier, Aseem Pandey, A. Shrestha, 2022, The Lancet Respiratory Medicine.

Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation

E. Sell, S. Kochhar, H. Marshall, 2017, Vaccine.

Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

S. Kochhar, J. Soul, M. Wiznitzer, 2019, Vaccine.

Enhanced passive safety surveillance of high‐dose and standard‐dose quadrivalent inactivated split‐virion influenza vaccines in Germany and Finland during the influenza season 2021/22

M. Nissilä, A. Shrestha, S. Wagué, 2022, Influenza and other respiratory viruses.

Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry

A. Shrestha, A. Khromava, T. Mallett Moore, 2021, Influenza and other respiratory viruses.

Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial.

Lee-Jah Chang, Aseem Pandey, A. Shrestha, 2023, Vaccine.